Home
Anaconda Pharma is a privately held biopharmaceutical company incorporated in November 2003 and operating from lab space within the BioTop incubator at the Pasteur Institute campus in Paris, France.
Targeting protein:protein interactions with small drugs
While small molecule drugs classically target enzymes, cellular receptors and ion channels, the majority of biological functions are facilitated by proteins interacting with other proteins. Antagonists of protein:protein interactions that have reached the market include therapeutic antibodies. Antibodies, however, have some drawbacks: high cost of production, lack of oral bioavailability and limited penetration inside of cells - i.e. a capacity to target only extracellular protein:protein interactions.
Anaconda Pharma is targeting protein:protein interactions with small molecules in the antiviral field.
Printable Page
 |
< HOME PAGE | © 2006 Anaconda Pharma |  |